Brian Edward Miller Sells 8,900 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Brian Edward Miller sold 8,900 shares of the firm’s stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at approximately $2,793,033.06. This represents a 60.72 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded up $3.58 during trading hours on Wednesday, reaching $497.30. The company had a trading volume of 2,557,102 shares, compared to its average volume of 1,425,097. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a market cap of $177.13 billion, a PE ratio of 77.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business has a fifty day simple moving average of $569.91 and a 200 day simple moving average of $531.84.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the company. Atala Financial Inc purchased a new stake in shares of Intuitive Surgical in the fourth quarter worth $25,000. Hurley Capital LLC bought a new position in Intuitive Surgical in the 4th quarter worth about $28,000. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $26,000. Parvin Asset Management LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $26,000. Finally, BankPlus Trust Department bought a new position in shares of Intuitive Surgical in the 4th quarter worth $28,000. 83.64% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

ISRG has been the subject of several recent analyst reports. Royal Bank of Canada upped their target price on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Truist Financial lifted their price target on shares of Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, CICC Research assumed coverage on shares of Intuitive Surgical in a report on Monday, January 27th. They set a “neutral” rating and a $550.00 price target for the company. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.